BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

July 2, 2020

View Archived Issues
Coronavirus vaccine, therapeutic illustration

Taxpayer-enabled COVID-19 vaccines will cost less, but distribution system requires another at-risk investment

The question of prices for a COVID-19 vaccine have raged in recent days. Gary Disbrow, acting director of the Biomedical Advanced Research and Development Authority (BARDA), told members of a Senate committee that vaccines developed with the help of taxpayer funding will come with an appropriate reduction in price. However, CDC Director Robert Redfield emphasized that the cold-chain distribution system for those products requires the same kind of at-risk investment that is used for vaccine development. Read More
AI-network-machine-learning.png

AI-focused Owkin rakes in an additional $18M to series A

LONDON – Owkin Inc. added a further $18 million to its series A, bringing the amount raised in the round to $70 million and equipping the company to push forward with its federated learning approach to applying artificial intelligence (AI) to the analysis of health data. Read More
Product image

Carag secures IDE approval for Bioresorbable Septal Occluder

Carag AG received investigational device exemption (IDE) approval from the U.S. FDA for its Carag Bioresorbable Septal Occluder (CBSO). The device is the first transcatheter septal occluder with a nonmetal, bioresorbable framework. The Baar, Switzerland-based company plans a "swift start" for a staged study trial in the U.S. with 250 patients, Carag's CEO Jérôme Bernhard told BioWorld. Read More
Money-financing

Deloitte unveils new health-tech accounting resources

With the push for value-based care, health care players – from manufacturers, to providers, to payers – are looking for ways to improve patient quality while reducing the costs of care. Advanced technologies, including digital health and artificial intelligence (AI)-based tools, are a major part of the equation, but companies face several challenges and barriers to adoption. To that end, management consultancy has launched a new Health Tech website featuring a Health Tech Industry Accounting Guide and other helpful advice for health-tech companies. Read More
Product image

Nanodx gets $18M to pursue fast, easy COVID-19, TBI tests; aims for market shortly

Startup Nanodiagnostics Inc. has been working for years toward a panel of point-of-care tests, helmed by one for traumatic brain injury. Read More
Disintegrating coronavirus

Snowballing research preps avalanche to bury COVID-19

Research focused on finding viable solutions to counter the COVID-19 pandemic continues at an explosive pace with a total of 588 potential therapeutics and vaccines at the forefront of scientific efforts launched by industry, academia and government. Read More

Holiday notice

BioWorld's offices will be closed in observance of Independence Day in the U.S. No issue will be published Friday, July 3. Read More

Appointments and advancements for July 2, 2020

New hires and promotions in the med-tech industry, including: Berkeley Lights, Gtx Medical, Rexgenero. Read More

Financings for July 2, 2020

Med-tech firms raising money in public or private financings, including: Biolase, Biolife Solutions, Inheart, Mimedx Group, Sofinnova Partners. Read More

In the clinic for July 2, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Berlin Heart, Osteolabs, Pulse Biosciences. Read More

Med-tech gainers and losers for June 29 - July 2, 2020

The top 10 med-tech stock gainers and losers for the week. Read More

Other news to note for July 2, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biosig, Electrical Geodesics, Fluxergy, Gravity Diagnostics, Haynes and Boone, Intouch Health, Kroger, Magstim, MRIglobal, Teladoc. Read More

Regulatory actions for July 2, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Life Whisperer, Phosphorus, Sagico, Spinal Elements. Read More

Regulatory front for July 2, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Agendia, Teva. Read More

BioWorld MedTech’s Diagnostics Extra for July 2, 2020

Keeping you up to date on recent developments in diagnostics, including: Broad scale genomic testing for childhood illness; Deep learning model for cancer prognosis; Placenta attachment theory. Read More

BioWorld MedTech Patent Highlights: Week 26

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette. Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing